Concepedia

Publication | Open Access

Ezetimibe-Simvastatin Therapy Reduce Recurrent Ischemic Stroke Risks in Type 2 Diabetic Patients

DOIFull Paper Access

22

Citations

33

References

2016

Year

Chi‐Hung Liu, Tien‐Hsing Chen, Ming‐Shyan Lin, Ming‐Jui Hung, Chang-Ming Chung, Wen‐Jin Cherng, Tsong‐Hai Lee, Yu‐Sheng Lin
The Journal of Clinical Endocrinology & Metabolism

Abstract

High-potency lipid-lowering therapy effectively reduces the risk of recurrent IS in diabetic patients regardless of ATOR or EZ-SIM combination therapy.

References

YearCitations

Page 1